I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 3.05 SEK -0.65% Market Closed
Market Cap: 208.8m SEK

Initiator Pharma A/S
Investor Relations

Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.

Show more
Loading
INIT
OMX Stockholm 30
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Claus Elsborg Olesen
Co-Founder, CEO & Director
No Bio Available
Dr. Dan Peters
Co-Founder & CTO
No Bio Available
Prof. Ulf Simonsen Ph.D.
Co-Founder, CMO & CSO
No Bio Available
Dr. Mikael Thomsen M.Sc., Ph.D.
Co-Founder & Chief Development Officer
No Bio Available
Dr. Torgeir Vaage Ph.D.
Chief Financial Officer
No Bio Available
Dr. Allan Wehnert
Senior Vice President of Clinical and R&D Strategy & Portfolio Management
No Bio Available
Susanne Thomsen
Head of Clin Ops
No Bio Available
Rene Egebro M.Sc.
Head of CMC
No Bio Available

Contacts

Address
KOEBENHAVN
Co/ COBIS, Ole Maaloeesvej 3
Contacts
www.initiatorpharma.com
sparklesyt

See Also

Summary
INIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
INIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INIT stock valuation using valuation multiples.
Wall Street Estimates
INIT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.